Loading data
BODINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 251.73 m USD | 418.8 m USD | 527.11 m USD | 692.2 m USD | 873.65 m USD |
| Cost of revenue | 67.94 m USD | 131.45 m USD | 204.02 m USD | 322.63 m USD | 328.66 m USD |
| Gross profit | 183.78 m USD | 287.34 m USD | 323.09 m USD | 369.57 m USD | 544.98 m USD |
| Research and development expense | 1.7 m USD | 1.6 m USD | 2.7 m USD | 4.4 m USD | 4.6 m USD |
| Operating profit | 5.53 m USD | -66.21 m USD | -140.99 m USD | -203.16 m USD | -297.32 m USD |
| Interest expense | 4.98 m USD | 6.88 m USD | 8.87 m USD | 3.37 m USD | 536 k USD |
| Profit before tax | -2.74 m USD | -71.4 m USD | -152.6 m USD | -197.25 m USD | -243.92 m USD |
| Income tax expense | 125 k USD | 239 k USD | 37 k USD | -3.05 m USD | -15.54 m USD |
| Net income (reported basis) | -2.86 m USD | -71.64 m USD | -152.64 m USD | -194.19 m USD | -228.38 m USD |
| Net income attributable to common shareholders | — | — | — | — | -228.38 m USD |
| Basic earnings per share | -0.41 USD/share | -10.51 USD/share | -24.47 USD/share | -31.58 USD/share | -0.83 USD/share |
| Diluted earnings per share | -0.41 USD/share | -10.51 USD/share | -24.47 USD/share | -31.58 USD/share | -0.83 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.